[go: up one dir, main page]

WO2001002563A3 - HUMAN PROTEINS HAVING HYDROPHOBIC DOMAINS AND DNAs ENCODING THESE PROTEINS - Google Patents

HUMAN PROTEINS HAVING HYDROPHOBIC DOMAINS AND DNAs ENCODING THESE PROTEINS Download PDF

Info

Publication number
WO2001002563A3
WO2001002563A3 PCT/JP2000/003943 JP0003943W WO0102563A3 WO 2001002563 A3 WO2001002563 A3 WO 2001002563A3 JP 0003943 W JP0003943 W JP 0003943W WO 0102563 A3 WO0102563 A3 WO 0102563A3
Authority
WO
WIPO (PCT)
Prior art keywords
proteins
hydrophobic domains
dnas encoding
dnas
human
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/JP2000/003943
Other languages
French (fr)
Other versions
WO2001002563A2 (en
Inventor
Seishi Kato
Tomoko Kimura
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sagami Chemical Research Institute
Protegene Inc
Original Assignee
Sagami Chemical Research Institute
Protegene Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sagami Chemical Research Institute, Protegene Inc filed Critical Sagami Chemical Research Institute
Priority to EP00937278A priority Critical patent/EP1196561A2/en
Priority to JP2001508335A priority patent/JP2003504021A/en
Priority to AU52498/00A priority patent/AU5249800A/en
Publication of WO2001002563A2 publication Critical patent/WO2001002563A2/en
Publication of WO2001002563A3 publication Critical patent/WO2001002563A3/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Cell Biology (AREA)
  • Immunology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

The present invention provides human proteins having hydrophobic domains, DNAs encoding these proteins, expression vectors for these DNAs, transformed eukaryotic cells expressing these DNAs and antibodies directed to these proteins.
PCT/JP2000/003943 1999-07-02 2000-06-16 HUMAN PROTEINS HAVING HYDROPHOBIC DOMAINS AND DNAs ENCODING THESE PROTEINS Ceased WO2001002563A2 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
EP00937278A EP1196561A2 (en) 1999-07-02 2000-06-16 HUMAN PROTEINS HAVING HYDROPHOBIC DOMAINS AND DNAs ENCODING THESE PROTEINS
JP2001508335A JP2003504021A (en) 1999-07-02 2000-06-16 Human protein having hydrophobic domain and DNA encoding the same
AU52498/00A AU5249800A (en) 1999-07-02 2000-06-16 Human proteins having hydrophobic domains and dnas encoding these proteins

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP18883599 1999-07-02
JP11/188835 1999-07-02

Publications (2)

Publication Number Publication Date
WO2001002563A2 WO2001002563A2 (en) 2001-01-11
WO2001002563A3 true WO2001002563A3 (en) 2001-07-05

Family

ID=16230684

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2000/003943 Ceased WO2001002563A2 (en) 1999-07-02 2000-06-16 HUMAN PROTEINS HAVING HYDROPHOBIC DOMAINS AND DNAs ENCODING THESE PROTEINS

Country Status (4)

Country Link
EP (1) EP1196561A2 (en)
JP (1) JP2003504021A (en)
AU (1) AU5249800A (en)
WO (1) WO2001002563A2 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7033790B2 (en) 2001-04-03 2006-04-25 Curagen Corporation Proteins and nucleic acids encoding same

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1157038A4 (en) * 1999-02-26 2005-01-19 Smithkline Beecham Corp Cloning of a p2y-like 7tm receptor (axor17)
US20060068464A1 (en) * 2000-03-16 2006-03-30 Shyam Ramkrishnan Regulation of human g protein coupled receptor
EP1297128A2 (en) * 2000-05-18 2003-04-02 Incyte Genomics, Inc. G-protein coupled receptors
WO2002022665A1 (en) * 2000-09-11 2002-03-21 Takeda Chemical Industries, Ltd. Novel g protein-coupled receptor proteins and dnas tehreof
WO2002029053A1 (en) * 2000-10-05 2002-04-11 Takeda Chemical Industries, Ltd. Novel g protein-coupled receptor protein and dna thereof
AU2002219063A1 (en) * 2000-10-31 2002-05-15 Bayer Aktiengesellschaft Human triacylglycerol lipase
WO2002079450A2 (en) * 2001-03-30 2002-10-10 Pe Corporation (Ny) Isolated human g-protein coupled receptors, nucleic acid molecules encoding human gpcr proteins, and uses thereof
AU2002258780A1 (en) 2001-04-11 2002-10-28 Bristol-Myers Squibb Company Polynucleotides encoding two novel human g-protein coupled receptors, hgprbmy28 and hgprbmy29, and splice variants thereof
US20030143668A1 (en) * 2001-06-18 2003-07-31 National Institute Of Advanced Industrial Guanosine triphosphate-binding protein coupled receptors
US7524638B1 (en) 2003-06-27 2009-04-28 Osi Pharmaceuticals, Inc. Methods for identification of modulators of OSGPR114 or OSGPR78 activity, and their use in the treatment of disease
BRPI0509420A (en) 2004-04-14 2007-09-04 Genentech Inc method of reducing or inhibiting angiogenesis and method of increasing efficacy of antiangiogenic agent treatment
WO2008010986A2 (en) 2006-07-17 2008-01-24 The Board Of Trustees Of The Leland Stanford Junior University Methods of modulating angiogenesis
BRPI1007706A2 (en) 2009-05-08 2019-04-02 Genentech, Inc. anti-egfl7 antibody, bispecific antibody, nucleic acid, vector, host cell, composition, method for producing an anti-egfl7 antibody, method of reducing or inhibiting angiogenesis in an individual, method of enhancing the effectiveness of an antiangiogenesis agent in an individual and method of reducing or inhibiting perfusion and permeability of a tumor in an individual

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1986001532A1 (en) * 1984-08-21 1986-03-13 Celltech Limited Polypeptide and polypeptide composition
WO1998021328A2 (en) * 1996-11-13 1998-05-22 Sagami Chemical Research Center Human proteins having transmembrane domains and dnas encoding these proteins

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1986001532A1 (en) * 1984-08-21 1986-03-13 Celltech Limited Polypeptide and polypeptide composition
WO1998021328A2 (en) * 1996-11-13 1998-05-22 Sagami Chemical Research Center Human proteins having transmembrane domains and dnas encoding these proteins

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
D'ANDREA ET AL: "Molecular Cloning of NKB1. A Natural Killer Cell Receptor for HLA-B Allotypes", JOURNAL OF IMMUNOLOGY,US,THE WILLIAMS AND WILKINS CO. BALTIMORE, vol. 155, no. 5, 1 September 1995 (1995-09-01), pages 2306 - 2310, XP002111500, ISSN: 0022-1767 *
DATABASE EMBL EBI; 1 September 1999 (1999-09-01), BIRREN ET AL.: "Homo sapiens chromosome 8 clone RP11-20I12", XP002151133 *
GILLEN C M ET AL: "Molecular cloning and functional expression of the K-Cl cotransporter from rabbit, rat, and human", JOURNAL OF BIOLOGICAL CHEMISTRY,US,AMERICAN SOCIETY OF BIOLOGICAL CHEMISTS, BALTIMORE, MD, vol. 271, no. 27, 5 July 1996 (1996-07-05), pages 16237 - 16244, XP002119528, ISSN: 0021-9258 *
KYTE J ET AL: "A SIMPLE METHOD FOR DISPLAYING THE HYDROPATHIC CHARACTER OF A PROTEIN", JOURNAL OF MOLECULAR BIOLOGY,GB,LONDON, vol. 157, no. 1, 5 May 1982 (1982-05-05), pages 105 - 132, XP000609503, ISSN: 0022-2836 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7033790B2 (en) 2001-04-03 2006-04-25 Curagen Corporation Proteins and nucleic acids encoding same

Also Published As

Publication number Publication date
AU5249800A (en) 2001-01-22
EP1196561A2 (en) 2002-04-17
JP2003504021A (en) 2003-02-04
WO2001002563A2 (en) 2001-01-11

Similar Documents

Publication Publication Date Title
WO2001049728A3 (en) HUMAN PROTEINS HAVING HYDROPHOBIC DOMAINS AND DNAs ENCODING THESE PROTEINS
WO2000005367A3 (en) Human proteins having hydrophobic domains and dnas encoding these proteins
WO2001012660A3 (en) HUMAN PROTEINS HAVING HYDROPHOBIC DOMAINS AND DNAs ENCODING THESE PROTEINS
WO2000029448A3 (en) Human proteins having hydrophobic domains and dnas encoding these proteins
AU4189799A (en) Prostate growth-associated membrane proteins
NO20016243D0 (en) Anti-alpha-beta3 recombinant human antibodies, nucleic acids encoding the same, and methods of recycling
WO2001002563A3 (en) HUMAN PROTEINS HAVING HYDROPHOBIC DOMAINS AND DNAs ENCODING THESE PROTEINS
AU2002228972A1 (en) Polynucleotide encoding chimeric protein and related vectors, cells, and methods of expression thereof
WO2004046365A3 (en) Interferon-alpha polypeptides and conjugates
EP1571216A3 (en) Phosphodiesterase 8A
WO2002059315A3 (en) Human nucleic acids and polypeptides and methods of use thereof
WO2000069884A3 (en) Compositions isolated from skin cells and methods for their use
HUP0103152A3 (en) Monoclonal antibodies directed against the g3bp protein, and uses
WO2002036627A3 (en) Interferons, uses and compositions related thereto
MXPA01003868A (en) Apomixis conferred by expression of serk interacting proteins.
WO1999049038A3 (en) Human calcium-binding proteins
WO2001004297A3 (en) Human proteins having hydrophobic domains and dnas encoding these proteins
WO1999009182A3 (en) Rab proteins
WO2001000824A3 (en) HUMAN PROTEINS HAVING HYDROPHOBIC DOMAINS AND DNAs ENCODING THESE PROTEINS
ZA99677B (en) Placental protein 13.
WO2000000506A3 (en) Human proteins having hydrophobic domains and dnas encoding these proteins
AU3452700A (en) Antibodies to placental protein 13
AU7478098A (en) Methods of treatment using nbs-1, antibodies and proteins thereto, and uses of the antibodies
WO2000019210A3 (en) Determining the mechanism of beta-amyloid peptide generation
WO2001000662A3 (en) The use of human fgh-8 polypeptides as neurotrophic agents

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
AK Designated states

Kind code of ref document: A3

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

ENP Entry into the national phase

Ref country code: JP

Ref document number: 2001 508335

Kind code of ref document: A

Format of ref document f/p: F

WWE Wipo information: entry into national phase

Ref document number: 2000937278

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 2000937278

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWW Wipo information: withdrawn in national office

Ref document number: 2000937278

Country of ref document: EP